3rd Circ. Won't Revive Chinese Co.'s GSK Probe Suit
The Third Circuit on Wednesday backed a lower court's ruling that a pair of consultants could not rely on U.S. racketeering laws to hold GlaxoSmithKline LLC liable for allegedly landing them in...To view the full article, register now.
Already a subscriber? Click here to view full article